Norway· NO-ID_70E587EB-59FD-4655-9C0B-E159AEFD4AA5
Tabrecta
A capmatinib product containing capmatinib, registered in Norway by Novartis Europharm Limited. The same ATC class is registered in 8 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Capmatinib is registered in 8 of 19 countries.
Countries holding a registration under ATC L01EP01 (capmatinib), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Capmatinib · ATC L01EP01
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Norwayprice
- United Statesprice
Price per daily dose
What a daily dose of capmatinib costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Capmatinib · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$319.09
The record
At a glance
FEST (Norway)- Active substance
- Capmatinib
- Manufacturer
- Novartis Europharm Limited
- Country
- Norway (NO)
- ATC code
- L01EP01
- ATC class
- Capmatinib
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_70E587EB-59FD-4655-9C0B-E159AEFD4AA5
- no_varenummer593980120NOK 110648.9
- gtin7613421059026
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
173 interactions on record for capmatinib.
Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Capmatinib · interactions on record
173 records
- 28 severe
- 136 moderate
- 9 minor
Most severe, free to view
- EdoxabanB01AF03severe
- DexamethasoneH02AB02severe
- KetoconazoleH02CA03severe
- ClarithromycinJ01FA09severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Capmatinib in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTABRECTANovartis Europharm Limited, Dublin
- FinlandTabrectaOrifarm Oy
- SpainTABRECTA 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULANovartis Europharm Limited
- IrelandTabrecta 150 mg film-coated tabletsNovartis Europharm Limited
- IcelandTabrectaNovartis Europharm Limited*
- NetherlandsTabrecta 150mg, filmomhulde tablettenNovartis Europharm Limited
- PolandTabrectaNovartis Europharm Limited
- SwedenTabrecta 150 mg Filmdragerad tablettNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Tabrecta
- Liechtenstein · Tabrecta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/70f5c7cc-f93a-41b6-863a-5e9790b328d8 GET /v1/drugs/70f5c7cc-f93a-41b6-863a-5e9790b328d8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett, filmdrasjert",
"source": "fest",
"status": "A",
"atc_name": "Kapmatinib",
"merkevare_id": "ID_70E587EB-59FD-4655-9C0B-E159AEFD4AA5",
"name_form_strength": "Tabrecta tab 150 mg",
"prescription_group": "C"
}See everything about capmatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.